FindTrial
Sign In

Application and dissemination of 3D ultrasound-guided "one-stop hybridization" minimally invasive atrial fibrillation treatment technology

Application and dissemination of 3D ultrasound-guided "one-stop hybridization" minimally invasive atrial fibrillation treatment technology

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084110
Enrollment
Unknown
Registered
2024-05-10
Start date
2020-01-06
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Experimental group:3D Ultrasound-Guided "One-Stop Hybrid" Atrial Fibrillation Ablation
Control group:Routine atrial fibrillation treatment surgery

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: Complex persistent atrial fibrillation; recurrence after previous catheter ablation; recurrence after surgical ablation of atrial fibrillation; markedly obese patients making mapping difficult.

Exclusion criteria

Exclusion criteria: Left atrial thrombus; previous cardiac surgery patients; extensive intrathoracic adhesions; poor respiratory function and difficult to tolerate anesthesia.

Design outcomes

Primary

MeasureTime frame
Heart rhythm;—

Secondary

MeasureTime frame
left atrial diameter;—

Countries

China

Contacts

Public ContactYongjun Qian

Department of cardiovascular surgery, West China Hospital, Sichuan University

qianyongjun@scu.edu.cn+86 189 8060 6851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026